Bruker Corporation  

(Public, NASDAQ:BRKR)   Watch this stock  
Find more results for ROBERT L. ROSENTHAL
23.75
+0.39 (1.67%)
Feb 12 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 23.14 - 24.18
52 week 15.78 - 25.23
Open 24.00
Vol / Avg. 2.37M/1.58M
Mkt cap 4.29B
P/E 39.50
Div/yield     -
EPS 0.60
Shares 167.88M
Beta 1.02
Inst. own 69%
May 4, 2016
Q1 2016 Bruker Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Feb 10, 2016
Q4 2015 Bruker Corp Earnings Call
Feb 10, 2016
Q4 2015 Bruker Corp Earnings Release
Jan 11, 2016
Bruker Corp at JPMorgan Healthcare Conference
Dec 3, 2015
Bruker Corp at ISI Medtools Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 12.97% 6.46%
Operating margin 14.78% 8.97%
EBITD margin - 14.63%
Return on average assets 13.92% 5.83%
Return on average equity 32.99% 13.56%
Employees 6,100 -
CDP Score - -

Address

40 MANNING RD
BILLERICA, MA 01821
United States - Map
+1-978-6633660 (Phone)
+1-978-6635585 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group, the Bruker CALID Group and the Bruker Nano Group. BEST designs, manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America, and it has sales offices located throughout the world.

Officers and directors

Frank H. Laukien Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
Anthony L Mattacchione Interim Chief Financial Officer, Senior Vice President - Finance & Accounting
Age: 51
Bio & Compensation  - Reuters
Bernd Gewiese Ph.D. Co-President of Bruker BioSpin Corporation
Age: 55
Bio & Compensation  - Reuters
Rene Lenggenhager President - Bruker BioSpin Group
Age: 55
Bio & Compensation  - Reuters
Werner E. Maas Ph.D. Co-President of Bruker BioSpin Corporation
Age: 49
Bio & Compensation  - Reuters
Mark R. Munch Ph.D. President, Bruker Nano Surfaces Division and Bruker MAT Group
Age: 53
Bio & Compensation  - Reuters
Juergen Srega President of Bruker CALID Group
Age: 60
Bio & Compensation  - Reuters
Michael Gunnar Knell Vice President - Finance, Chief Accounting Officer
Age: 38
Bio & Compensation  - Reuters
William A. Linton Lead Independent Director
Age: 67
Bio & Compensation  - Reuters
Joerg C. Laukien Director
Age: 61
Bio & Compensation  - Reuters